SJ
Satish Jindal
General Partner at Advent Life Sciences
Cambridge, Massachusetts
Overview
Satish Jindal is a General Partner at Advent Life Sciences in Cambridge, Massachusetts, with a strong background in fundraising and extensive experience in the biotechnology and pharmaceutical industry. Notable highlights of his career include serving as the CEO of BioMotiv and Elicio Therapeutics, as well as holding executive positions at Bristol-Myers Squibb and Schering-Plough Research Institute.
Work Experience
General Partner
2022 - Current
Through partnership with BioMotiv
Board Member and Co-founder
2014 - 2022
CEO
2019 - 2021
Co-Founder/Founding CEO
2010 - 2019
Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.
Raised $253,831,801.00 from GKCC.
CEO
2014 - 2019
Vice President, BMS;
2011 - 2014
Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.
Raised $23,580,000,000.00 from RA Capital Management, OUP (Osage University Partners), Aperture Venture Partners, Greg Bailey, Connecticut Innovations, Knoll Capital Management, Vivo Capital, Venrock, Litmore Capital and Carl Icahn.
President/COO; Co-founder
2009 - 2011
VP and Site Head
2005 - 2008
CEO, Founder, Chairman, BoD
1997 - 2005
Senior Director
1995 - 1996